No Picture
Trading Ideas

Beyond Meat Stock Surges to Start 2020: Restaurant Chains to the Rescue

Beyond Meat stock is on the rise this January. In fact, shares have skyrocketed more than 60% in the first three weeks of 2020. The Los Angeles-based company is enjoying a market spike due to the recent push for more plant-based meat substitutes by restaurant chains.
Beyond Meat (NYSE: BYND) is making its way into menus of major chains across the country. Moreover, rival Impossible Foods is falling behind after their Burger King “Impossible Whopper” took a sales hit.

Why is Beyond Meat Stock Flourishing?
Partnerships are the key to the success of Beyond Meat stock at this very moment. On Monday, sit-down …read more […]

No Picture
Trading Ideas

4 Sources to Find Unclaimed Money and Assets

Americans have lost billions of dollars. Could some of it be yours? With a simple search, you might find a small fortune of unclaimed assets that could be yours. That’s what happened to one man in South Carolina. He found $763,000 in unclaimed cash.
That’s life-changing money, no doubt… but he could have found it sooner. The following guide will show you why so much money is forgotten. You’ll also learn how to find unclaimed money and assets.

How Billions in Unclaimed Money and Property Pile Up
Have you found quarters stuffed between the couch covers? People lose change all the time. The …read more […]

No Picture
Trading Ideas

Goldman Sachs: 3 Healthcare Stocks to Snap Up Now

Stuck for fresh investing inspiration? You’re not alone. After the stock market’s record-breaking performance in 2019, plenty of uncertainty lingers on Wall Street as we go forward into 2020. The U.S. presidential election coupled with new fears related to the spread of the coronavirus, which pushed the S&P 500 down 1.6% yesterday, have driven concerns that 2020 will see its fair share of volatility.Against this backdrop, investment banking giant Goldman Sachs published a report containing valuable insights. Highlighting the healthcare services sector in particular, the firm notes that while it anticipates fourth quarter results will fall in line with expectations, …read more […]

Newsmakers

NexTech (OTC: NEXCF) Signs Partner Agreement with Jolokia Bringing AR to the Global Learning and Development Industry

AR and Interactive Video combine to create world’s most compelling training platform NEW YORK and TORONTO, Jan. 28, 2020– NexTech AR Solutions (the “Company” or “NexTech”) (otcqb:NEXCF) (NTAR)(N29) NexTech AR Solutions, the industry leader in […]

No Picture
Trading Ideas

BorgWarner to Buy Delphi for $1.5 Billion in Auto-Parts Deal

(Bloomberg) — BorgWarner Inc. agreed to acquire Delphi Technologies Plc for about $1.5 billion in an all-stock deal that unites two auto suppliers positioning for the industry’s transformational shift to hybrid and electric vehicles.The deal values Delphi Technologies at about $3.3 billion including debt, according to a statement Tuesday. Its shares surged a record 66% to $16.30, the highest intraday since September. BorgWarner plunged as much as 8.4% to $35.14, the lowest since October.Both BorgWarner and Delphi’s engine and transmission businesses are expected to enter a period of decline as carmakers consolidate and pivot to electric cars. The suppliers have …read more […]

No Picture
Trading Ideas

3M to Cut 1,500 Jobs in Global Restructuring

(Bloomberg) — 3M Co. dropped the most in nine months after revealing it had received a grand jury subpoena in an environmental probe and saying it would cut 1,500 jobs amid slumping markets including car parts and electronics.The pared workforce is part of a restructuring — affecting “all business groups, functions and geographies” — starting this month that will recast reporting lines and consolidate manufacturing oversight, 3M said in a statement Tuesday as it reported earnings. The company anticipates pretax savings of as much as $120 million a year from the changes.The cuts, on top of 2,000layoffs announced in April, …read more […]

Healthcare

CytoDyn’s (OTC: CYDY) Leronlimab Under Evaluation for Potential Treatment of Coronavirus

CytoDyn and IncellDX in discussions with potential partners about the use of leronlimab to treat 2019 Novel Coronavirus (2019-nCoV) VANCOUVER, Washington, Jan. 28, 2020  — CytoDyn Inc. (otc.qb:CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology […]